UCLA study finds pre-surgery immunotherapy safe for pancreatic cancer patients

FHS
April 6, 2024
3:51 am

A pilot study led by UCLA Health Jonsson Comprehensive Cancer Center investigators suggests that for people with borderline resectable pancreatic cancer, administrating an immunotherapy drug in combination with chemotherapy before surgery is safe and may improve long-term outcomes.

European Union Grants €6.5M for Multi-Site Psilocybin Study in Palliative Patients – Psychedelic Alpha

Psilocybin therapy has shown promise in improving psycho-spiritual wellbeing in patients with life-threatening cancer, as demonstrated by Griffiths et al. (2016), Shnayder et al. (2023),

January 24, 2024

How Did the Supreme Court Rule on Mifepristone?

The 24-hour news cycle is just as important to medicine as it is to politics, finance, or sports. At MedPage Today, new information is posted

June 16, 2024

Among pregnant people, active treatment for addiction shouldn’t trigger a call to child protective services

Methadone and buprenorphine, both FDA-approved drugs, are considered the gold standard for treating opioid use disorder. They are so effective, in fact, that they are

June 5, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.